Barrx 32041-18-01Recalls & reported problems
Covidien LP · 360 RFA Balloon Catheter · Class 2
All models of Barrx (19)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10884521189300), received between Aug 23, 2018 and Aug 23, 2018 — classified as 1 injury.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
Patient problems
- Chest Pain1
- Pain1
- Stenosis1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
InjuryAug 23, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ADULTS WITH DIAGNOSIS OF HIGH-GRADE DYSPLASIA (3) AND MUCOSAL SQUAMOUS CELL CARCINOMAS (7) UNDERWENT CIRCUMFERENTIAL ABLATIONS. FOUR OF THE 7 PATIENTS HAD A HISTORY OF HEAD AND NECK CANCERS, AND 4 HAD A HISTORY OF CIRRHOSIS. ALL PATIENTS HAD LESIONS THAT OCCUPIED MORE THAN HALF OF THE CIRCUMFERENCE OF THE ESOPHAGUS, AND 3 PATIENTS HAD CIRCUMFERENTIAL EXTENSION. PATIENTS UNDERWENT PRIMARY ABLATIONS CIRCUMFERENTIALLY USING THE HALO360 SYSTEM (CONCOMITANT PRODUCTS ENERGY GENERATOR, AND A SIZING BALLOON). ALL PATIENTS UNDERWENT CIRCUMFERENTIAL RFA WITH A DOUBLE-ABLATION REGIMEN (12 J/CM2¿ CLEAN ¿ 12 J/CM2). AFTER ENDOSCOPIC ABLATION, PATIENTS WERE PROVIDED WITH ESOMEPRAZOLE 40 MG/DAY AND SUCRALFATE SUSPENSION 5 ML (200 MG/ML) 4 TIMES DAILY FOR 1 MONTH. ACETAMINOPHEN AND AN ORAL NARCOTIC WERE PRESCRIBED AS NEEDED. PATIENTS LOGGED POSTABLATION SYMPTOMS TO RECORD CHEST PAIN, THROAT PAIN, ODYNOPHAGIA AND DYSPHAGIA. PATIENTS RECEIVED FOLLOW-UP ENDOSCOPY WITH IMAGE ENHANCING MODALITIES, INCLUDING LUGOL STAINING AND NARROW-BAND IMAGING. THIS WAS PERFORMED 1, 3, AND 6 MONTHS AFTER THE PROCEDURE AND EVERY 6 MONTHS THEREAFTER. IF RESIDUAL SQUAMOUS INTRAEPITHELIAL NEOPLASMS WERE DETECTED DURING F
Patient problems: Chest Pain; Pain; Stenosis
MAUDE report 7810581 ↗
Other Electrosurgical, Cutting & Coagulation & Accessories devices
- Vasoview Hemopro 2 VH-4000Maquet Cardiovascular LLC · Electrosurgical, Cutting & Coagulation & Accessories6 recalls1 death3,232 reports
- LigaSure LF1937Covidien LP · Electrosurgical, cutting & coagulation & accessories3 deaths2,090 reports
- Olympus WB91051WOLYMPUS Winter & Ibe GmbH · Electrosurgical, Cutting & Coagulation & Accessories1 death1,951 reports
- Valleylab FT10 VLFT10GENCovidien LP · Electrosurgical, cutting & coagulation & accessories1 recall5 deaths1,062 reports
- LigaSure LF1837Covidien LP · ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES1 recall967 reports
- LigaSure LF2019Covidien LP · Electrosurgical, cutting & coagulation & accessories948 reports
- VAPR 225028Depuy Mitek, LLC · ELECTROSURGICAL, CUTTING & COAGULATION & ACCESSORIES895 reports
- LigaSure LF1923Covidien LP · Electrosurgical, cutting & coagulation & accessories855 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page